Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations.
about
Tumor necrosis factor-alpha hyper-responsiveness to endotoxin in whole blood is associated with chronic bronchitis in farmersComparing antibiotics for acute exacerbations of chronic obstructive pulmonary diseaseComparing antibiotics for acute exacerbations of chronic obstructive pulmonary diseaseEosinophilic bronchitis: clinical manifestations and implications for treatmentEffects of inhaled corticosteroids on sputum cell counts in stable chronic obstructive pulmonary disease: a systematic review and a meta-analysisMMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbationCOPD and stroke: are systemic inflammation and oxidative stress the missing links?Bacterial-viral load and the immune response in stable and exacerbated COPD: significance and therapeutic prospectsExacerbations of COPDEfficacy and Safety of Aclidinium/Formoterol versus Tiotropium in COPD: Results of an Indirect Treatment ComparisonBronchiectasis as a Comorbidity of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-AnalysisFine particulate matter in acute exacerbation of COPDChronic bronchitis and chronic obstructive pulmonary diseaseMechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary diseasePharmacological strategies to reduce exacerbation risk in COPD: a narrative reviewCough and its importance in COPDPersistence of oxidant and protease burden in the airways after smoking cessation.Cytokine inhibition in the treatment of COPD.Investigating the role of pentraxin 3 as a biomarker for bacterial infection in subjects with COPD.Chronic obstructive pulmonary disease treated with inhaled medium- or high-dose corticosteroids: a prospective and randomized study focusing on clinical efficacy and the risk of pneumonia.Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial.Domiciliary pulse-oximetry at exacerbation of chronic obstructive pulmonary disease: prospective pilot studyEffect of lianhuaqingwen capsules on airway inflammation in patients with acute exacerbation of chronic obstructive pulmonary disease.Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPDMechanisms of action and clinical application of macrolides as immunomodulatory medications.Oral corticosteroids for exacerbations of chronic obstructive pulmonary disease.Oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease.Impact of a functional polymorphism in the PAR-1 gene promoter in COPD and COPD exacerbationsIncreased cytokine response of rhinovirus-infected airway epithelial cells in chronic obstructive pulmonary disease.Role of th17 cell and autoimmunity in chronic obstructive pulmonary disease.Increased levels of soluble interleukin-6 receptor and CCL3 in COPD sputum.Markers of active airway inflammation and remodelling in chronic obstructive pulmonary disease.Electronic cigarette liquid increases inflammation and virus infection in primary human airway epithelial cellsCellular and structural bases of chronic obstructive pulmonary disease.Macrophage migration inhibitory factor promotes tumor growth in the context of lung injury and repairIncreased of exhaled breath condensate neutrophil chemotaxis in acute exacerbation of COPD.25-hydroxyvitamin D deficiency, exacerbation frequency and human rhinovirus exacerbations in chronic obstructive pulmonary disease.Relationship between periodontitis-related antibody and frequent exacerbations in chronic obstructive pulmonary disease.The causes and consequences of seasonal variation in COPD exacerbations.Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD.
P2860
Q23912968-981CE3A4-1F38-4D87-B122-523B75015B89Q24234366-2F712559-883A-43F2-B451-EF1A4D760E57Q24243833-B3B73242-5F5E-477A-BC29-6BBC8FA23C0BQ24678904-2C97393A-A00A-4A74-835B-8240DF5E9E10Q24797765-9AF4FFDA-E540-48B5-A915-370829C7E42FQ25256354-C66618B0-97E8-4EA8-B0E7-487DE8C26375Q26746530-3EC90936-C67E-4C01-9803-EF316131DF51Q26752882-44316191-7492-4C04-A973-601F5387A1A7Q26764891-D799FFF7-2E24-476C-8460-3A3E26AA1A69Q26765425-5EF97951-0AB7-4A45-9054-22F793BEDC5EQ26765486-48648F99-82B3-4DAC-82F9-4870FCF7DB11Q26777960-689F7AB6-BF2A-4181-BAC0-AF7AEA9B2FDEQ26991702-C407F721-6ED0-4EFC-B9BF-F9F723AFB3A5Q27000043-3BAA508D-D708-4734-8E12-30167F38F895Q28070274-DCED00F6-12FE-4B1C-A69B-C414A942EDE3Q30488037-3E075340-7C22-4223-984C-FFF5C8C67C91Q33453893-F8550594-EF78-47CC-A4F9-5D1720911C29Q33568552-61F7E3B2-18F8-4959-A280-7A4B414EBB28Q33596515-092CE100-5CD5-4E86-AB41-136134FDC2ABQ33709357-F4F21B36-0DF1-466B-BC44-9B7B1F5B3E90Q33711672-0EBFF0A3-6412-4547-8218-B4B1E2CECAF2Q33723544-5E8DBAA8-4050-4176-814C-F1E66A9F261BQ33757519-02AD82BC-A494-4E59-9DD5-88C4CEC1BB86Q33776839-25FEDDEE-8483-4AAE-A252-3EA1992D0876Q33983140-F61AC215-3BE0-4AEC-A803-24EE1078F9E9Q34004412-CC2B9866-5D6D-43B3-B8BC-3C47DFF76CBBQ34042468-06EC2FFE-C264-470F-82BF-5A2CBCFBDD5AQ34062965-27AF25FC-5476-4307-9E05-42B91F000003Q34065620-E6E1EAFD-49CB-4DA9-A0B0-C7948D063643Q34127425-A346BA79-BEF1-4166-B220-2262F6CF917AQ34145804-4D057BF3-B59A-4288-A58F-4ED30ED26B39Q34184746-C9183692-1575-42BE-8D66-2813918231C4Q34227089-53618BC0-6988-41A2-A271-3DCA0F76077DQ34260279-F5DCA323-D3D1-4596-B3AC-C89B0821D0B7Q34268934-125121F0-B231-4043-9BC6-84863613EA3EQ34274539-E95959F0-D539-45AF-A8F1-33E19F99A614Q34315062-3E4B63E7-6711-4C37-B0CA-46D34BB07009Q34336540-6F970D46-6A5E-4D55-8E03-E9E0CCFBB900Q34353043-3D8E0BEB-0D8B-44B6-A081-22E0813C411EQ34447539-E4D517DA-91B2-4D4A-AB59-20FFA4DEA4DF
P2860
Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Relation of sputum inflammator ...... changes in COPD exacerbations.
@ast
Relation of sputum inflammator ...... changes in COPD exacerbations.
@en
type
label
Relation of sputum inflammator ...... changes in COPD exacerbations.
@ast
Relation of sputum inflammator ...... changes in COPD exacerbations.
@en
prefLabel
Relation of sputum inflammator ...... changes in COPD exacerbations.
@ast
Relation of sputum inflammator ...... changes in COPD exacerbations.
@en
P2093
P2860
P356
P1433
P1476
Relation of sputum inflammator ...... changes in COPD exacerbations.
@en
P2093
Sapsford RJ
Seemungal TA
Wedzicha JA
P2860
P304
P356
10.1136/THORAX.55.2.114
P407
P577
2000-02-01T00:00:00Z